Dina Visca Selected Research

Dina Visca Research Topics

Disease

11	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 07/2014
10	Asthma (Bronchial Asthma) 02/2024 - 01/2018
6	Inflammation (Inflammations) 02/2024 - 01/2011
6	Dyspnea (Shortness of Breath) 06/2023 - 01/2017
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 04/2013
4	COVID-19 11/2023 - 01/2021
4	Lung Diseases (Lung Disease) 01/2020 - 01/2017
3	Rhinosinusitis 02/2024 - 12/2020
3	Extensively Drug-Resistant Tuberculosis 04/2019 - 04/2018
2	Nasal Polyps (Nasal Polyp) 02/2024 - 08/2022
2	Pulmonary Tuberculosis 01/2024 - 01/2019
2	Infections 09/2022 - 01/2021
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 04/2013
2	Disease Progression 01/2021 - 04/2013
2	Respiratory Insufficiency (Respiratory Failure) 12/2020 - 12/2014
2	Hypoxia (Hypoxemia) 12/2020 - 10/2018
2	Chronic Cough 11/2020 - 01/2020
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2019 - 01/2018
1	Eosinophilia 02/2024
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021
1	Body Weight (Weight, Body) 08/2021
1	Malnutrition (Nutritional Deficiencies) 03/2020
1	Chronic Bronchitis 01/2020
1	Cough 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Bronchitis 01/2020
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2020
1	Human Influenza (Influenza) 10/2019
1	Albuminuria 10/2019
1	Renal Insufficiency (Renal Failure) 10/2019
1	Bacterial Infections (Bacterial Infection) 04/2019
1	Tuberculosis (Tuberculoses) 04/2019
1	Sleepiness 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2018
1	Heart Failure 07/2014
1	Idiopathic Pulmonary Fibrosis 04/2013
1	Lactose Intolerance (Intolerance, Lactose) 01/2008
1	Food Hypersensitivity (Food Allergy) 01/2008

Drug/Important Bio-Agent (IBA)

10	Oxygen (Dioxygen)IBA 11/2023 - 07/2014
3	Bronchodilator Agents (Bronchodilators)IBA 05/2024 - 05/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 12/2019
3	GasesIBA 08/2021 - 12/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2013
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2020
2	VaccinesIBA 01/2021 - 10/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 11/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 03/2020 - 01/2011
2	bedaquiline (R207910)IBA 01/2019 - 01/2018
1	SteroidsIBA 02/2024
1	dupilumabIBA 02/2024
1	Thyroid HormonesIBA 01/2023
1	BCG Vaccine FDA Link 09/2022
1	mepolizumabIBA 08/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	cupric sulfide (CuS)IBA 10/2021
1	Monoclonal AntibodiesIBA 12/2020
1	MacrolidesIBA 11/2020
1	Gabapentin (Neurontin)FDA LinkGeneric 11/2020
1	Opioid Analgesics (Opioids)IBA 11/2020
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2020
1	CreatinineIBA 10/2019
1	Nicotine FDA Link 10/2019
1	Hypertonic Saline SolutionIBA 07/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	OPC-67683IBA 01/2018
1	Carbon DioxideIBA 07/2014
1	Interleukin-8 (Interleukin 8)IBA 04/2013
1	CytokinesIBA 04/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013
1	Interleukin-6 (Interleukin 6)IBA 04/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2013
1	Interleukin-10 (Interleukin 10)IBA 04/2013
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2011
1	beta-Galactosidase (Lactaid)IBA 01/2008

Therapy/Procedure

11	Therapeutics 05/2024 - 01/2008
2	Aftercare (After-Treatment) 01/2024 - 11/2020
2	Respiratory Therapy (Therapy, Respiratory) 01/2020 - 01/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2018 - 12/2014
1	Breathing Exercises 06/2023
1	Combined Modality Therapy 12/2020
1	Endurance Training 12/2020
1	Biological Therapy 12/2020
1	Nebulizers and Vaporizers (Inhaler) 01/2020
1	Critical Care (Surgical Intensive Care) 04/2019
1	Nutritional Support (Artificial Feeding) 04/2019
1	Duration of Therapy 04/2018
1	Noninvasive Ventilation 12/2014